# SORAFENIB TOSYLATE
> **ANDA212228** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2025-01-27
## Drug
- **FDA Application Number:** ANDA212228
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SORAFENIB TOSYLATE
- **Generic name:** Sorafenib Tosylate
- **Active ingredients:** SORAFENIB TOSYLATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** APOTEX
- **First approval:** 2025-01-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212228)
---
*AI Analytics · CC0 1.0*